Pharmafocus

@Pharmafocus

Monthly pharmaceutical, biotech & healthcare news publication for the UK, Europe and worldwide. Site updated daily with latest , & news.

London, UK
pharmafile.com
Vrijeme pridruživanja: prosinac 2008.
3.151 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @Pharmafocus

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Pharmafocus

  1. Prikvačeni tweet
    30. sij

    With the story so far on the Wuhan and a special feature on 2020's US presidential candidates and their plans to tackle the , the January/February edition of Pharmafocus is free to read online now!

    Poništi
  2. prije 42 sekunde

    Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds.

    Poništi
  3. prije 2 sata

    In our latest feature, investigates how developments in AI are looking to offset costs by improving patient recruitment for trials and their adherence during testing.

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  4. prije 5 sati

    NICE plans to use broader range of data in guidance

    1 korisnik označava da mu se sviđa
    Poništi
  5. prije 5 sati

    Bayer's Eylea shows strong vision benefits across two regimens in post-marketing study

    Poništi
  6. prije 5 sati

    Final UK flight from Wuhan to bring home Britons from coronavirus epicenter

    Poništi
  7. prije 6 sati

    Seqirus' Audenz becomes first FDA-approved cell-based adjuvant A vaccine:

    Poništi
  8. prije 7 sati

    Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds

    Poništi
  9. prije 23 sata

    Europe's CHMP recommends Pfizer's biosimilar of Roche's MabThera

    Poništi
  10. prije 23 sata

    National Institutes of Health terminates vaccine after it proves ineffective

    Poništi
  11. prije 23 sata

    New study casts doubt on effectiveness of psychotherapy treatments for military-related PTSD.

    1 korisnik označava da mu se sviđa
    Poništi
  12. prije 24 sata

    Sanofi charged in birth defects case in France.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  13. 4. velj

    China admits its coronavirus response had “shortcomings”.

    Poništi
  14. 4. velj

    New study casts doubt on effectiveness of psychotherapy treatments for military-related PTSD

    1 korisnik označava da mu se sviđa
    Poništi
  15. 4. velj

    Europe's CHMP recommends Pfizer's biosimilar of Roche's MabThera

    Poništi
  16. 4. velj

    Sanofi charged in birth defects case in France

    2 korisnika označavaju da im se sviđa
    Poništi
  17. 4. velj

    National Institutes of Health terminates vaccine after it proves ineffective

    2 korisnika označavaju da im se sviđa
    Poništi
  18. 4. velj

    China admits its coronavirus response had “shortcomings”

    Poništi
  19. 3. velj

    Insider Interview: AstraZeneca's Rodrigo Gribble breaks down recently published data for ticagrelor, a potential new treatment for patients with coronary artery disease, and how this may benefit patients who have suffered from previous heart attacks.

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  20. 3. velj

    BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell

    Poništi
  21. 3. velj

    AbbVie's Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic

    Poništi

@Pharmafocus još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·